Share
Back to top
Alzheimer's
-
Imagine reversing the course of conditions like Alzheimer's or multiple sclerosis, in which cells of the central nervous system stop working or die. Researchers at Johnson & Johnson are hot on the trail of innovative solutions that may do just that, preventing often-debilitating symptoms along the way.
-
Injections that allow people with schizophrenia to go longer between treatments. Digital tools that may lead to the creation of more effective medications. Programs that ensure mental illness is properly diagnosed. These are just a few of the ways Johnson & Johnson is addressing the largest unmet need in healthcare.
-
With COVID-19 dominating the news this year, chances are you've also read about clinical studies that are underway for investigational vaccines. For a glimpse at what the experience of participating in a clinical study is like, we spoke to people across the country who took part in a clinical trial.
-
Johnson & Johnson and the National Academy of Medicine have collaborated on a competition to kick-start research that's poised to revolutionize the field of healthy longevity. Meet some of the researchers who have big ideas in the pursuit of "immorbidity."
-
It's the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
-
Cancer. Alzheimer’s. Even suicide risk. The clues to preventing these and other conditions could be found in our DNA—and these scientists are at the forefront of promising new genetic data research to uncover them.
-
Johnson & Johnson aspires to change the trajectory of health for humanity. And Tom Heyman helps make that lofty goal a reality through his work as the head of Johnson & Johnson's venture capital division, which invests in dozens of companies each year. He shares what's on his radar for 2019.
-
With company leaders at the World Economic Forum in Davos this week, Johnson & Johnson's Chief Scientific Officer weighs in on the next great global healthcare challenge—and how we can all come together to help address it.
-
From the incredible researchers who've dedicated their life's work to fighting chronic diseases to those who work tirelessly to bring hope to underserved populations, we're taking a moment to celebrate the company's many heroes.
-
Diagnostic tests. Clinical trials. A vaccine. For Alzheimer's Awareness Month, we sat down with scientists at Janssen Research & Development to learn how their work has the potential to alter the future of how we detect and treat the disease.
-
These up-and-coming stars in oncology, immunology, anti-aging, vaccines and other areas of research are helping to change healthcare as we know it. And they're just at the beginning of their brilliant careers.
-
On Women's Equality Day, we're celebrating Johnson & Johnson, JLABS entrepreneurs who are working on innovations—like a simple way to detect Alzheimer's before it manifests—that have the potential to improve the healthcare industry.
-
Husseini Manji, M.D., is working toward a world in which diseases like depression and schizophrenia are diagnosed quickly and handled without stigma. His team's discoveries in the lab may just get us there.
-
Your immune system does so much more than simply fight off colds. For National Autoimmune Disease Awareness Month, we spoke to scientists who are harnessing this vital defense system to fight diseases in ways you likely never imagined.
-
They share one thing in common: a goal of transforming the way illnesses are treated in the most forward-thinking way possible. Meet three innovators whose ideas could someday change the future of healthcare.
